Trexquant Investment LP Kal Vista Pharmaceuticals, Inc. Transaction History

Trexquant Investment LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$11.07 - $16.04 $613,765 - $889,321	55,444 New	55,444 $657,000
Q2 2022 Aug 11, 2022	BUY	$8.16 - $15.1 $318,631 - $589,624	39,048 New	39,048 $384,000
Q1 2022 May 13, 2022	SELL	$11.2 - $16.97 $191,867 - $290,713	-17,131 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$12.36 - $18.28 $24,806 - $36,687	-2,007 Reduced 10.49%	17,131 $227,000
Q3 2021 Nov 12, 2021	BUY	$17.11 - $24.49 $327,451 - $468,689	19,138 New	19,138 $334,000
Q3 2020 Nov 06, 2020	SELL	$9.83 - $13.99 $129,451 - $184,234	-13,169 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$6.75 - $12.89 $88,890 - $169,748	13,169 New	13,169 $159,000
Q4 2019 Feb 12, 2020	SELL	$10.31 - $17.81 $162,887 - $281,380	-15,799 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$11.6 - $21.67 $183,268 - $342,364	15,799 New	15,799 $183,000

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $220M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.